Trial Profile
Clinical Trial to Assess the Pharmacokinetic Characteristics of CJ-30060 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Amlodipine/rosuvastatin/valsartan (Primary) ; Amlodipine/valsartan; Rosuvastatin
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors CJ HealthCare; HK inno.N
- 07 Jan 2017 New trial record